OncoBuddy4baseCare
OncoBuddy is a digital oncology companion platform that supports patients and clinicians throughout the cancer‑care journey. It unifies clinical data, patient‑reported outcomes, and personalized guidance in one intuitive interface.
Vendor
4baseCare
Company Website
Product details
OncoBuddy
OncoBuddy is a digital oncology companion platform that supports patients and clinicians throughout the cancer‑care journey. It unifies clinical data, patient‑reported outcomes, and personalized guidance in one intuitive interface. By combining continuous monitoring, structured care pathways, AI‑supported insights, and seamless communication, OncoBuddy enhances treatment accuracy, improves patient engagement, reduces complexity for clinical teams, and enables more coordinated, data‑driven cancer care.
Features
- Secure patient environment for symptom tracking and treatment updates
- Direct messaging channel between patients and oncology care teams
- Upload and management of medical reports, scans, and treatment documents
- Personalized reminders for medications, appointments, and follow‑up tasks
- Clinician dashboard providing real‑time visibility into patient status
- Intelligent alerts highlighting cases requiring urgent clinical review
Capabilities
- Consolidation of clinical, genomic, and patient‑reported data into unified insights
- Continuous remote patient monitoring across treatment cycles
- AI‑assisted insights to support therapy optimization
- Multidisciplinary collaboration tools for oncology teams
- Structured digital care pathways guiding patients through treatment phases
- Flexible support for telehealth, outpatient, and in‑clinic workflows
Benefits
- More precise clinical decision‑making through integrated, comprehensive data
- Reduced administrative workload due to streamlined communication
- Higher patient engagement and adherence enabled by guided digital support
- Earlier detection of complications through continuous monitoring
- Improved coordination across the oncology care continuum
- Better overall outcomes enabled by personalized, connected cancer care